CHA News Article

August Holds Important Dates for Hospitals Participating in 340B Discount Drug Program

The month of August features some key dates and deadlines for hospitals participating in the federal 340B discount drug program. Aug. 7 marks the end of the delay period for 340B disproportionate share hospitals, children’s hospitals and freestanding cancer hospitals to reach compliance with the Health Resources and Services Administration’s (HRSA) group purchasing organization (GPO) prohibition requirements. On Aug. 8, HRSA will host a public webinar from 11 a.m. – noon (ET) on the recently released final rule on the 340B orphan drug exclusion. To access the webinar, dial (888) 324-2913, using the passcode 3184054 and the webinar link. Finally, HRSA will begin its annual recertification process for all 340B hospitals on Aug. 19 and will close the process Sept. 13, with no extensions. The recertification process requires hospitals subject to the GPO prohibition or orphan drug exclusion to attest that they are compliant. Additional resources are available through Apexus, HRSA’s contracted 340B Prime Vendor Program, at